Home › Funds › Redmile Group, LLC › STTK
Redmile Group, LLC position in STTK
SHATTUCK LABS INC · Health Care
Redmile Group, LLC reported holding 6,892,033 shares of STTK (SHATTUCK LABS INC) in its Q2 2026 13F filing — a position valued at US$47.8M, representing 3.21% of its reported portfolio and ranking #9 among its reported holdings. Redmile Group, LLC has disclosed STTK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Redmile Group, LLC's STTK position evolved
Redmile Group, LLC first disclosed a stake in STTK in Q3 2023 at 5,619,914 shares (US$8.5M). The position peaked in Q1 2024 at 5,615,489 shares, worth US$50.2M. Across 12 filings, Redmile Group, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 6,892,033 shares valued at US$47.8M — an increase of 1,352,309 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 5.62M | $8.54M | New |
| Q4 2023 | 5.62M | $40.07M | Hold |
| Q1 2024 | 5.62M | $50.20M | Hold |
| Q2 2024 | 5.62M | $21.68M | Hold |
| Q3 2024 | 5.62M | $19.60M | Hold |
| Q4 2024 | 5.54M | $6.70M | Reduce |
| Q1 2025 | 5.54M | $5.26M | Hold |
| Q2 2025 | 5.54M | $4.39M | Hold |
| Q3 2025 | 5.54M | $13.24M | Hold |
| Q4 2025 | 5.54M | $20.22M | Hold |
| Q1 2026 | 5.54M | $35.62M | Hold |
| Q2 2026 | 6.89M | $47.83M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About STTK and 13F data
STTK (SHATTUCK LABS INC) is a Health Care company. 57 other funds we track also report a position in STTK — the largest reported positions include ORBIMED ADVISORS LLC (US$43.8M), Prosight Management, LP (US$41.3M), Frazier Life Sciences Management, L.P. (US$26.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STTK
- ORBIMED ADVISORS LLC 6.31M sh · $43.76M · Q2 2026
- Prosight Management, LP 5.96M sh · $41.35M · Q2 2026
- Frazier Life Sciences Management, L.P. 3.75M sh · $26.02M · Q2 2026
- NEXTBio Capital Management LP 3.73M sh · $25.87M · Q2 2026
- Deep Track Capital, LP 3.71M sh · $25.72M · Q2 2026
- CLARK ESTATES INC/NY 1.43M sh · $9.93M · Q2 2026
- Boxer Capital Management, LLC 1.00M sh · $6.94M · Q2 2026
- S&G Foundation 435.75K sh · $3.02M · Q2 2026
- West Tower Group, LLC 191.62K sh · $1.31M · Q3 2026
- LBJ Family Wealth Advisors, Ltd. 82.18K sh · $560.00K · Q3 2026
More on Redmile Group, LLC
FAQ
How long has Redmile Group, LLC held STTK?
Redmile Group, LLC has disclosed STTK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Redmile Group, LLC's current position in STTK?
As of Q2 2026, Redmile Group, LLC holds 6.89M shares of STTK (SHATTUCK LABS INC), valued at $47.83M, representing 3.21% of its reported portfolio and ranking #9.
Has Redmile Group, LLC been buying or selling STTK?
In the latest 13F filing (Q2 2026), Redmile Group, LLC increased its position in STTK. The position peaked in Q1 2024 at 5.62M shares.
Which other funds hold STTK?
Other major institutional holders of STTK include ORBIMED ADVISORS LLC, Prosight Management, LP, Frazier Life Sciences Management, L.P., among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.